Drug Shortage Report for TARO-SUNITINIB
| Report ID | 173745 |
| Drug Identification Number | 02524066 |
| Brand name | TARO-SUNITINIB |
| Common or Proper name | SUNITINIB |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SUNITINIB |
| Strength(s) | 25MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 3X10 |
| ATC code | L01EX |
| ATC description | |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2022-09-22 |
| Estimated end date | 2023-01-13 |
| Actual end date | 2022-11-30 |
| Shortage status | Resolved |
| Updated date | 2022-12-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-12-12 | French | Compare |
| v7 | 2022-12-12 | English | Compare |
| v6 | 2022-11-24 | French | Compare |
| v5 | 2022-11-24 | English | Compare |
| v4 | 2022-11-15 | French | Compare |
| v3 | 2022-11-15 | English | Compare |
| v2 | 2022-11-04 | French | Compare |
| v1 | 2022-11-04 | English | Compare |
Showing 1 to 8 of 8